Larry P. Feigen

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

Abla A. Creasey, Alvin Chang, Larry P. Feigen et al. · Journal of Clinical Investigation · 1993 · 554 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +15

Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2

Philip J. Kadowitz, B. M. Chapnick, Larry P. Feigen et al. · Journal of Applied Physiology · 1978 · 150 citations

Medicine, Cardiology, Pharmacology +16

The Amino-terminal One-third of αIIb Defines the Ligand Recognition Specificity of Integrin αIIbβ3

Joseph C. Loftus, Carol Halloran, Mark H. Ginsberg et al. · Journal of Biological Chemistry · 1996 · 74 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.

Ethan J. Haskel, S P Adams, Larry P. Feigen et al. · Circulation · 1989 · 66 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

SC-54684A: An Orally Active Inhibitor of Platelet Aggregation

Nancy S. Nicholson, Susan G. Panzer‐Knodle, Anita K. Salyers et al. · Circulation · 1995 · 65 citations

Medicine, Hematology, Pharmacology +17